
Grove: A preclinical biotech startup innovating biotherapeutics for unmet medical needs.
Founded as a seed-stage platform biotechnology company, Grove Biopharma is dedicated to pioneering the discovery and development of innovative biotherapeutics aimed at challenging drug targets with significant unmet medical needs. The company's core mission is to create first-in-class drugs using their proprietary Precision-Linked Proteomimetics™ (PLPs), a novel class of customizable, synthetic biologics designed to target intracellular protein-protein interactions.
Grove Biopharma has garnered attention from notable investors and industry leaders due to its cutting-edge approach in the biotech sector. The company's key achievements include the successful development of their PLP platform, which has shown promise in preclinical studies. By focusing on unmet medical needs, Grove Biopharma aims to make a substantial impact on healthcare, potentially offering new treatment options for diseases that currently lack effective therapies.

GRO Biosciences
grobio.com

Groove Biopharma

Orange Grove Bio
orangegrovebio.com

ProFound Therapeutics
profoundtx.com

Curie.Bio
curie.bio

Petri Bio
petribio.com

Deep Apple Therapeutics
deepappletx.com

20n Bio
20n.bio

Metaphore Biotechnologies
metaphorebio.com

Juvena Therapeutics

Empirico
empiricotx.com

Vibe Bio
vibebio.com

Orchid BioVentures

Ampersand Biomedicines
ampersand.bio

Granata Bio
granata.bio
Companies similar to Grove Biopharma include GRO Biosciences, Groove Biopharma, Orange Grove Bio and ProFound Therapeutics.
Grove Biopharma was founded in 2020.
Grove Biopharma's headquarters is located in Chicago, IL, US.
Grove Biopharma's most recent funding round was for $2.5M (USD) in June 2022.
As of Jun 30, 2022, Grove Biopharma has raised a total of $10.5M (USD).
Grove Biopharma has 8 employees as of Feb 4, 2024.